Unknown

Dataset Information

0

Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease.


ABSTRACT:

SUBMITTER: Sun Q 

PROVIDER: S-EPMC8164054 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3458470 | biostudies-literature
| S-EPMC9839384 | biostudies-literature
| S-EPMC7850424 | biostudies-literature
| S-EPMC10535379 | biostudies-literature
| S-EPMC6849407 | biostudies-literature
| S-EPMC10374058 | biostudies-literature
| S-EPMC7574915 | biostudies-literature
| S-EPMC3704121 | biostudies-literature
| S-EPMC6069798 | biostudies-literature
| S-EPMC3094059 | biostudies-literature